What are TransMedics Group, Inc.'s profit margins?

TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.

Where do TransMedics Group, Inc.'s ratios come from?

Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

TransMedics Group, Inc. TMDX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	59.1%-0.4pp	59.9%+0.6pp	60.3%+0.9pp	59.8%-0.9pp	59.5%-2.9pp
Operating margin	14.9%+4.1pp	17.9%+9.4pp	16.9%+9.7pp	14.4%+15.4pp	10.8%+16.4pp
Net margin	27%+17.0pp	31.4%+23.4pp	16.2%—	13.5%—	10%—
EBITDA margin	20%+4.8pp	22.4%+9.5pp	21.4%+9.8pp	18.9%+15.8pp	15.2%+17.1pp
Free cash flow margin	23.8%—	22.1%—	——	——	——
Returns
Return on equity	45.2%+22.2pp	54.2%+34.8pp	32.5%—	28.2%—	23%—
Return on assets	15.1%+8.9pp	20.3%+15.6pp	10.6%—	8.7%—	6.3%—
Return on invested capital	40.5%—	——	——	——	——
Efficiency
Asset turnover	0.6×-0.1×	0.6×+0.1×	0.7×+0.1×	0.6×+0.1×	0.6×0.0×
Inventory turnover	5.6×+1.3×	5.1×+1.1×	4.7×+1.1×	4.9×+1.3×	4.3×+1.2×
Liquidity
Current ratio	6.7×-2.4×	7.1×-1.2×	7.7×-0.5×	9.9×+0.5×	9.1×-0.6×
Quick ratio	6.2×-2.1×	6.6×-0.9×	7.1×-0.2×	9.2×+0.7×	8.3×-0.4×
Cash ratio	5×-0.6×	5.5×-0.2×	5.8×+0.4×	7.1×+0.4×	5.6×-1.4×
Leverage
Debt-to-equity	0.8×+0.6×	0.1×-0.2×	0.2×-0.1×	0.2×-0.1×	0.3×-0.2×
Debt-to-assets	0.3×+0.2×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Net debt / EBITDA	-0.4×+2.9×	-3.1×+1.6×	-3.3×+2.3×	-3.3×+23.5×	-3.3×—
Interest coverage	5.4×+1.7×	7.9×+5.3×	6.9×+4.9×	5.4×+5.7×	3.7×+4.9×
Per Share
Book value per share	$13.65+105%	$11.67+79.8%	$8.72+48.2%	$7.84+45.7%	$6.67+45.1%
Valuation
Market capitalization	$3.41B+50.6%	$4.16B+98.7%	$3.82B-27.1%	$4.49B-10.0%	$2.26B-6.5%
Enterprise value	$3.36B+66.0%	$3.74B+105%	$3.43B-31.3%	$4.15B-11.5%	$2.02B-5.5%
Price / earnings	19.8×-26.4×	21.8×-37.2×	41.7×—	62.6×—	46.3×—
Price / sales	5.4×+0.7×	6.9×+2.1×	6.8×-6.3×	8.4×-5.5×	4.6×-3.5×
Price / book	6.9×-1.6×	8.8×-0.4×	10.8×-14.2×	14.1×-12.2×	8.5×-6.7×
EV / EBITDA	26.4×-0.9×	27.5×-4.3×	28.2×-79.0×	41.4×-386×	27.3×—
EV / sales	5.3×+1.1×	6.2×+2.0×	6×-6.4×	7.8×-5.3×	4.1×-3.1×
Free cash flow yield	4.4%—	3.2%—	——	——	——
Earnings yield	5%+2.9pp	4.6%+2.9pp	2.4%—	1.6%—	2.2%—
PEG ratio	0.1×—	0.1×—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about TransMedics Group, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are TransMedics Group, Inc.'s profit margins?: TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.
Where do TransMedics Group, Inc.'s ratios come from?: Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.